Valeant receives approval for secondary supplier of Methoxsalen - Pharmaceutical Business Review

Valeant receives approving for secondary supplier of Methoxsalen Pharmaceutical Business revaluation Valeant Pharmaceuticals has declared the FDA approval of an additional manufacturer of Methoxsalen USP, an constitutional component of a attention for the relief of moderate to severe disease of the skin . It is unarbitrary under the brand linguistic unit Oxsoralen-Ultra ... FDA Approves Additional Manufacturer of Methoxsalen Benzinga all 3 tidings articles » Link To Article